Clinical and Imaging Characteristics in Patients with SARS-CoV-2 Infection and Acute Intracranial Hemorrhage
Authors:
- Jawed NawabiJNJawed Nawabi
- Andrea MorottiAMAndrea Morotti
- Moritz WildgruberMoritz Wildgruber
- Gregoire BoulouisGBGregoire Boulouis
- Hermann KraehlingHKHermann Kraehling
- Frieder SchlunkFSFrieder Schlunk
- Elif CanECElif Can
- Helge KniepHKHelge Kniep
- Götz ThomallaGTGötz Thomalla
- Marios PsychogiosMarios Psychogios
- Bernd HammBHBernd Hamm
- Jens FiehlerJFJens Fiehler
Open Access
- 6 August 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 9 (8) , 2543
Abstract
Background and Purpose: Intracranial hemorrhage has been observed in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19), but the clinical, imaging, and pathophysiological features of intracranial bleeding during COVID-19 infection remain poorly characterized. This study describes clinical and imaging characteristics of patients with COVID-19 infection who presented with intracranial bleeding in a European multicenter cohort. Methods: This is a multicenter retrospective, observational case series including 18 consecutive patients with COVID-19 infection and intracranial hemorrhage. Data were collected from February to May 2020 at five designated European special care centers for COVID-19. The diagnosis of COVID-19 was based on laboratory-confirmed diagnosis of SARS-CoV-2. Intracranial bleeding was diagnosed on computed tomography (CT) of the brain within one month of the date of COVID-19 diagnosis. The clinical, laboratory, radiologic, and pathologic findings, therapy and outcomes in COVID-19 patients presenting with intracranial bleeding were analyzed. Results: Eighteen patients had evidence of acute intracranial bleeding within 11 days (IQR 9–29) of admission. Six patients had parenchymal hemorrhage (33.3%), 11 had subarachnoid hemorrhage (SAH) (61.1%), and one patient had subdural hemorrhage (5.6%). Three patients presented with intraventricular hemorrhage (IVH) (16.7%). Conclusion: This study represents the largest case series of patients with intracranial hemorrhage diagnosed with COVID-19 based on key European countries with geospatial hotspots of SARS-CoV-2. Isolated SAH along the convexity may be a predominant bleeding manifestation and may occur in a late temporal course of severe COVID-19.Keywords
This publication has 40 references indexed in Scilit:
- Diagnosing CNS VasculitisThe Neurologist, 2012
- Adult primary central nervous system vasculitisCurrent Opinion in Rheumatology, 2012
- Primary central nervous system vasculitis presenting with intracranial hemorrhageArthritis & Rheumatism, 2011
- Isolated Acute Nontraumatic Cortical Subarachnoid HemorrhageAmerican Journal of Neuroradiology, 2010
- SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARSEuropean Journal of Clinical Investigation, 2009
- Virus-induced vasculitisCurrent Rheumatology Reports, 2008
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Endothelial DysfunctionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Cerebral vasculitis: MR imaging and angiographic correlation.Radiology, 1992
- Intracranial Pressure Monitoring in Comatose Patients With Cerebral HemorrhageArchives of Neurology, 1984